Skip to content
Screener

Alumis Inc. ALMS Finance Lease Liabilities (Total)

Finance Lease Liabilities (Total) at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$152K-61.6%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.54B+686%
Enterprise value$3.52B+940%
P/S421.8×—

Profitability

See full
Operating margin-5,364%—
Net margin-2,825.7%—
FCF margin-4,487.4%—

Returns & leverage

See full
Return on equity-64.6%—
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.

The source filing: Alumis Inc.’s 10-K, filed March 19, 2026.

Filed
Mar 19, 2026, 4:23 PM EDT
Fiscal year
FY2025
Accession
0001847367-26-000006

As of December 31, 2025 and 2024, the Company had no finance leases.

Item 8. Financial Statements and Supplementary Data

FAQ

What is Alumis Inc.'s finance lease liabilities (total)?
Alumis Inc. (ALMS) reported finance lease liabilities (total) of $0 in Q4 2025.
What does finance lease liabilities (total) mean?
Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.

Ask your AI about Alumis Inc.'s finance lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude